LORATADINE PSEUDOEPHEDRINE SULFATE

LORATADINE PSEUDOEPHEDRINE SULFATE was reported 6366 times

LORATADINE PSEUDOEPHEDRINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOFOLLICULITIS BARBAE 3 0.1250
1 ACANTHOMA 2 0.0385
2 DRUG EFFECT DELAYED 80 0.0176
3 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 6 0.0137
4 AORTIC ATHEROSCLEROSIS 2 0.0137
5 ILIOTIBIAL BAND SYNDROME 3 0.0133
6 ANAL DISCOMFORT 2 0.0130
7 PARANASAL SINUS HYPOSECRETION 3 0.0120
8 AMPHETAMINES POSITIVE 8 0.0107
9 SINUS POLYP 5 0.0087
10 CERVICAL CYST 2 0.0085
11 CAROTID BRUIT 3 0.0078
12 CHOLESTEROSIS 2 0.0078
13 BRONCHITIS ACUTE 3 0.0075
14 DRUG EFFECT DECREASED 394 0.0073
15 CORONARY ARTERY ATHEROSCLEROSIS 3 0.0071
16 FEELING JITTERY 134 0.0070
17 BUNION 5 0.0070
18 FOREIGN BODY TRAUMA 5 0.0068
19 STATUS ASTHMATICUS 3 0.0064
20 CUBITAL TUNNEL SYNDROME 2 0.0059
21 NASAL DRYNESS 36 0.0057
22 CEREBRAL ARTERIOSCLEROSIS 2 0.0052
23 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 30 0.0044
24 ALLERGY TO PLANTS 2 0.0044
25 PAINFUL DEFAECATION 3 0.0043
26 POOR QUALITY SLEEP 90 0.0042
27 OTITIS MEDIA ACUTE 3 0.0041
28 EXPIRED DRUG ADMINISTERED 19 0.0038
29 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 3 0.0038
30 GALLBLADDER INJURY 7 0.0036
31 TONSILLAR DISORDER 4 0.0036
32 COLON INJURY 2 0.0035
33 CYSTOCELE 3 0.0035
34 CORONARY ARTERY RESTENOSIS 2 0.0033
35 NASAL PRURITUS 4 0.0032
36 ACTINOMYCOSIS 3 0.0031
37 BILIARY DYSKINESIA 5 0.0029
38 URINE FLOW DECREASED 7 0.0029
39 FRACTURE NONUNION 4 0.0029
40 ACUTE SINUSITIS 5 0.0029
41 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
42 CHRONIC FATIGUE SYNDROME 4 0.0029
43 BLOOD OESTROGEN DECREASED 2 0.0028
44 THERAPEUTIC PRODUCT INEFFECTIVE 11 0.0028
45 PRODUCT COMMINGLING 3 0.0028
46 AMINO ACID LEVEL INCREASED 2 0.0027
47 EPICONDYLITIS 4 0.0026
48 EXTRA DOSE ADMINISTERED 106 0.0026
49 LUMBAR RADICULOPATHY 3 0.0026
50 LIP ULCERATION 3 0.0026
51 ENERGY INCREASED 15 0.0025
52 COVID-19 IMMUNISATION 2 0.0024
53 PARANASAL SINUS DISCOMFORT 9 0.0024
54 APTYALISM 2 0.0023
55 THERAPEUTIC RESPONSE UNEXPECTED 105 0.0023
56 OBSTRUCTION GASTRIC 3 0.0023
57 FOREIGN BODY IN RESPIRATORY TRACT 3 0.0023
58 DRUG SCREEN POSITIVE 18 0.0023
59 LIP EXFOLIATION 3 0.0023
60 EXPIRED PRODUCT ADMINISTERED 75 0.0023
61 PRODUCT PACKAGE ASSOCIATED INJURY 5 0.0022
62 INSOMNIA 596 0.0022
63 DRUG EFFECT INCREASED 7 0.0022
64 RHONCHI 3 0.0022
65 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
66 LOBAR PNEUMONIA 4 0.0022
67 SEBORRHOEIC KERATOSIS 3 0.0021
68 DIABETES MELLITUS NON-INSULIN-DEPENDENT 3 0.0021
69 NASAL SEPTUM DEVIATION 4 0.0020
70 COLON ADENOMA 2 0.0020
71 CARDIAC ANEURYSM 2 0.0020
72 PRODUCT USE ISSUE 377 0.0020
73 DRY MOUTH 161 0.0020
74 DRY THROAT 20 0.0020
75 EYE ALLERGY 3 0.0019
76 NERVOUSNESS 101 0.0019
77 PRE-EXISTING CONDITION IMPROVED 12 0.0019
78 PHYSICAL ASSAULT 4 0.0019
79 TINEA PEDIS 3 0.0019
80 NASAL DISORDER 5 0.0019
81 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 2 0.0018
82 INCORRECT DOSAGE ADMINISTERED 9 0.0018
83 ONYCHOMYCOSIS 8 0.0018
84 PLEURITIC PAIN 5 0.0018
85 DRUG SCREEN FALSE POSITIVE 5 0.0018
86 BLOOD CALCIUM ABNORMAL 3 0.0018
87 MITRAL VALVE PROLAPSE 3 0.0018
88 CHOLECYSTITIS CHRONIC 12 0.0018
89 THIRST 32 0.0018
90 HEPATOCELLULAR DAMAGE 4 0.0018
91 DRUG EFFECT INCOMPLETE 64 0.0018
92 INITIAL INSOMNIA 18 0.0018
93 CERVICAL SPINAL STENOSIS 3 0.0017
94 CEREBRAL VENTRICLE DILATATION 2 0.0017
95 DILATATION ATRIAL 2 0.0017
96 LUMBAR SPINAL STENOSIS 5 0.0017
97 PULMONARY INFARCTION 4 0.0017
98 DYSURIA 62 0.0017
99 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
100 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
101 BREATH ODOUR 4 0.0016
102 NASAL DISCOMFORT 13 0.0016
103 ESSENTIAL HYPERTENSION 3 0.0016
104 TENSION HEADACHE 7 0.0016
105 HYPERTENSIVE HEART DISEASE 3 0.0016
106 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
107 FOREIGN BODY IN THROAT 5 0.0016
108 RHINITIS ALLERGIC 7 0.0016
109 PARANASAL SINUS HYPERSECRETION 6 0.0016
110 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
111 MOTION SICKNESS 3 0.0016
112 URINARY TRACT DISORDER 7 0.0016
113 VENTRICULAR DYSFUNCTION 4 0.0015
114 EPIGASTRIC DISCOMFORT 6 0.0015
115 ABDOMINAL HERNIA 7 0.0015
116 ANAEMIA POSTOPERATIVE 2 0.0015
117 SNEEZING 34 0.0015
118 PALPITATIONS 172 0.0015
119 AGORAPHOBIA 2 0.0015
120 TACHYPHRENIA 5 0.0014
121 DILATATION VENTRICULAR 3 0.0014
122 APPENDIX DISORDER 2 0.0014
123 PRODUCT SOLUBILITY ABNORMAL 7 0.0014
124 TRICUSPID VALVE INCOMPETENCE 11 0.0014
125 PRODUCT PACKAGING ISSUE 13 0.0014
126 SEASONAL ALLERGY 19 0.0013
127 FEAR OF DEATH 3 0.0013
128 CHRONIC SINUSITIS 5 0.0013
129 MITRAL VALVE INCOMPETENCE 15 0.0013
130 UNEVALUABLE EVENT 99 0.0013
131 SYNOVIAL CYST 6 0.0013
132 OESOPHAGEAL DISORDER 5 0.0013
133 SENSATION OF HEAVINESS 5 0.0013
134 PRODUCT PRESCRIBING ISSUE 28 0.0013
135 SPINAL COLUMN STENOSIS 6 0.0013
136 ABDOMINAL ADHESIONS 4 0.0013
137 THERAPEUTIC RESPONSE CHANGED 8 0.0013
138 LACUNAR INFARCTION 3 0.0013
139 CYSTITIS INTERSTITIAL 2 0.0012
140 SOMNOLENCE 248 0.0012
141 COSTOCHONDRITIS 2 0.0012
142 DERMAL CYST 3 0.0012
143 CARTILAGE INJURY 3 0.0012
144 FEELING DRUNK 9 0.0012
145 ARTHROPOD STING 2 0.0012
146 VENTRICULAR HYPERTROPHY 3 0.0012
147 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
148 HEPATIC CYST 4 0.0012
149 LACTOSE INTOLERANCE 3 0.0012
150 DIFFICULTY IN WALKING 4 0.0012
151 TENSION 7 0.0011
152 MULTIPLE ALLERGIES 9 0.0011
153 HEART RATE INCREASED 112 0.0011
154 PHARYNGOLARYNGEAL PAIN 6 0.0011
155 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33 0.0011
156 MIDDLE INSOMNIA 21 0.0011
157 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
158 BREAST SWELLING 3 0.0011
159 RHINORRHOEA 72 0.0011
160 IRON DEFICIENCY 5 0.0011
161 SINUS CONGESTION 15 0.0011
162 BONE LESION 4 0.0011
163 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
164 LACRIMATION INCREASED 33 0.0011
165 RHINALGIA 3 0.0011
166 EUPHORIC MOOD 11 0.0011
167 BURSITIS 13 0.0011
168 BLOOD IRON INCREASED 2 0.0011
169 GALLBLADDER DISORDER 19 0.0011
170 CHOLECYSTITIS ACUTE 6 0.0011
171 HYPERTONIC BLADDER 3 0.0010
172 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
173 DRUG INEFFECTIVE 1350 0.0010
174 PROSTATOMEGALY 4 0.0010
175 HEAD DISCOMFORT 18 0.0010
176 RESTLESSNESS 37 0.0010
177 SINUS HEADACHE 6 0.0010
178 CHOLECYSTITIS 12 0.0010
179 ANEURYSM 5 0.0010
180 LOW TURNOVER OSTEOPATHY 4 0.0010
181 CORONARY ARTERY STENOSIS 5 0.0010
182 MASTICATION DISORDER 3 0.0010
183 TRIGGER FINGER 4 0.0010
184 CHANGE OF BOWEL HABIT 2 0.0010
185 INCREASED UPPER AIRWAY SECRETION 5 0.0010
186 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
187 DIASTOLIC DYSFUNCTION 3 0.0010
188 TALIPES 3 0.0010
189 LACERATION 9 0.0010
190 BLINDNESS TRANSIENT 7 0.0009
191 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
192 LOOSE TOOTH 3 0.0009
193 PRODUCT SIZE ISSUE 5 0.0009
194 CARDIAC FLUTTER 6 0.0009
195 CARDIAC MURMUR 8 0.0009
196 INCORRECT DRUG ADMINISTRATION DURATION 26 0.0009
197 HERPES SIMPLEX 6 0.0009
198 PHARYNGEAL OEDEMA 14 0.0009
199 SINUS DISORDER 18 0.0009
200 OTITIS MEDIA 3 0.0009
201 PLANTAR FASCIITIS 3 0.0009
202 PRODUCT LABEL ISSUE 6 0.0009
203 RESPIRATORY TRACT CONGESTION 14 0.0009
204 EAR DISCOMFORT 9 0.0009
205 BRONCHOPNEUMONIA 3 0.0009
206 RHINITIS 7 0.0009
207 NASAL CONGESTION 51 0.0009
208 EYE PRURITUS 29 0.0009
209 CAROTID ARTERY STENOSIS 3 0.0009
210 ROSACEA 4 0.0009
211 HYPOVOLAEMIA 5 0.0009
212 FLANK PAIN 8 0.0009
213 HANGOVER 3 0.0009
214 LOGORRHOEA 3 0.0009
215 GLOSSITIS 3 0.0008
216 DIVERTICULUM 6 0.0008
217 MEDICATION RESIDUE PRESENT 4 0.0008
218 PHARYNGITIS STREPTOCOCCAL 9 0.0008
219 HUMERUS FRACTURE 4 0.0008
220 ATELECTASIS 8 0.0008
221 ACCIDENTAL OVERDOSE 30 0.0008
222 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 45 0.0008
223 BRONCHITIS CHRONIC 2 0.0008
224 DRUG ABUSER 5 0.0008
225 NASAL POLYPS 4 0.0008
226 SCOLIOSIS 5 0.0008
227 TENDON INJURY 3 0.0008
228 PHARYNGITIS 10 0.0008
229 CYST 10 0.0008
230 OVARIAN CYST 8 0.0008
231 GROIN PAIN 7 0.0008
232 SPINAL OSTEOARTHRITIS 7 0.0008
233 IRRITABLE BOWEL SYNDROME 17 0.0008
234 PATHOLOGICAL FRACTURE 4 0.0008
235 MICTURITION URGENCY 9 0.0008
236 GINGIVAL DISORDER 3 0.0008
237 CEREBRAL ISCHAEMIA 4 0.0008
238 AORTIC ARTERIOSCLEROSIS 2 0.0008
239 ANOREXIA 10 0.0008
240 BLOOD CHLORIDE DECREASED 2 0.0008
241 TENDONITIS 12 0.0008
242 PANIC DISORDER 3 0.0008
243 FEELING ABNORMAL 185 0.0008
244 FAECES HARD 3 0.0008
245 ACTINIC KERATOSIS 2 0.0008
246 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
247 ANOSMIA 11 0.0008
248 POLYDIPSIA 3 0.0008
249 GINGIVAL PAIN 6 0.0008
250 CEREBRAL ATROPHY 3 0.0008
251 SINUSITIS 77 0.0008
252 ANGIONEUROTIC OEDEMA 2 0.0007
253 BREAST PAIN 8 0.0007
254 POST-TRAUMATIC STRESS DISORDER 5 0.0007
255 STRESS FRACTURE 4 0.0007
256 CHEILITIS 4 0.0007
257 CHONDROPATHY 2 0.0007
258 ABDOMINAL RIGIDITY 2 0.0007
259 CLUMSINESS 2 0.0007
260 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
261 NECROSIS 4 0.0007
262 CHOKING 14 0.0007
263 ATRIAL SEPTAL DEFECT 6 0.0007
264 ANAL HAEMORRHAGE 2 0.0007
265 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
266 CARPAL TUNNEL SYNDROME 10 0.0007
267 AORTIC VALVE INCOMPETENCE 3 0.0007
268 LUNG NEOPLASM 3 0.0007
269 THINKING ABNORMAL 13 0.0007
270 METASTATIC NEOPLASM 3 0.0007
271 MUSCLE STRAIN 6 0.0007
272 MOUTH SWELLING 4 0.0007
273 CHAPPED LIPS 3 0.0007
274 WRONG TECHNIQUE IN DRUG USAGE PROCESS 25 0.0007
275 URINE OUTPUT DECREASED 6 0.0007
276 SLUGGISHNESS 7 0.0007
277 DIVERTICULUM INTESTINAL 3 0.0007
278 MELANOCYTIC NAEVUS 3 0.0007
279 INJURY 48 0.0007
280 EYE DISCHARGE 7 0.0007
281 PLEURISY 4 0.0007
282 FACIAL PAIN 6 0.0007
283 CREPITATIONS 2 0.0007
284 BRAIN HERNIATION 2 0.0007
285 TOOTHACHE 12 0.0007
286 LIP DRY 6 0.0007
287 RESTLESS LEGS SYNDROME 12 0.0007
288 EXOSTOSIS 6 0.0007
289 RETCHING 14 0.0007
290 NO THERAPEUTIC RESPONSE 8 0.0007
291 HAEMATOCRIT DECREASED 13 0.0007
292 ABNORMAL DREAMS 18 0.0007
293 GRAND MAL CONVULSION 6 0.0006
294 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
295 BLOOD PRESSURE INCREASED 99 0.0006
296 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
297 MASS 9 0.0006
298 CHOLELITHIASIS 21 0.0006
299 VAGINAL INFECTION 3 0.0006
300 TOOTH FRACTURE 7 0.0006
301 SPUTUM DISCOLOURED 6 0.0006
302 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 45 0.0006
303 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
304 BLADDER PAIN 2 0.0006
305 SLEEP APNOEA SYNDROME 12 0.0006
306 BILE DUCT STONE 2 0.0006
307 POLLAKIURIA 26 0.0006
308 SLEEP DISORDER 44 0.0006
309 ROTATOR CUFF SYNDROME 8 0.0006
310 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 21 0.0006
311 ANGINA UNSTABLE 4 0.0006
312 HEPATITIS ACUTE 4 0.0006
313 INFLAMMATORY BOWEL DISEASE 6 0.0006
314 DEAFNESS NEUROSENSORY 2 0.0006
315 BLADDER DISORDER 6 0.0006
316 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
317 DERMATITIS EXFOLIATIVE 3 0.0006
318 HYPOAESTHESIA ORAL 9 0.0006
319 CORONARY ARTERY DISEASE 18 0.0006
320 OSTEOPENIA 9 0.0006
321 COLITIS ISCHAEMIC 4 0.0006
322 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
323 PRODUCT TASTE ABNORMAL 8 0.0006
324 HYPERLIPIDAEMIA 7 0.0006
325 FEMORAL NECK FRACTURE 3 0.0006
326 CROHN'S DISEASE 4 0.0006
327 ECCHYMOSIS 4 0.0006
328 TEMPERATURE INTOLERANCE 6 0.0006
329 STOMACH DISCOMFORT 3 0.0006
330 LYMPHOEDEMA 4 0.0006
331 FORMICATION 4 0.0006
332 AORTIC STENOSIS 2 0.0006
333 DIZZINESS 285 0.0006
334 PRODUCT USE COMPLAINT 9 0.0006
335 URINARY RETENTION 19 0.0006
336 CARDIOMEGALY 7 0.0006
337 TINNITUS 26 0.0006
338 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
339 ANGINA PECTORIS 16 0.0006
340 FEAR 15 0.0006
341 BRUXISM 3 0.0006
342 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
343 PANIC REACTION 4 0.0006
344 DEEP VEIN THROMBOSIS 36 0.0006
345 IRRITABILITY 33 0.0005
346 ASTHENOPIA 3 0.0005
347 ORAL DISORDER 4 0.0005
348 HYPERKERATOSIS 3 0.0005
349 PROSTATIC DISORDER 3 0.0005
350 INCREASED TENDENCY TO BRUISE 5 0.0005
351 OSTEOARTHRITIS 23 0.0005
352 IRON DEFICIENCY ANAEMIA 5 0.0005
353 LIP SWELLING 18 0.0005
354 ARTHROPOD BITE 4 0.0005
355 TOOTH DISORDER 12 0.0005
356 HYPERHIDROSIS 69 0.0005
357 ANGIOPATHY 3 0.0005
358 ORAL CANDIDIASIS 7 0.0005
359 PAROSMIA 4 0.0005
360 PERONEAL NERVE PALSY 3 0.0005
361 CARDIAC VALVE DISEASE 3 0.0005
362 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
363 VISUAL DISTURBANCE 3 0.0005
364 BOWEL MOVEMENT IRREGULARITY 4 0.0005
365 DRUG PRESCRIBING ERROR 10 0.0005
366 FOOD ALLERGY 4 0.0005
367 HYPERCHOLESTEROLAEMIA 5 0.0005
368 AGITATION 38 0.0005
369 ANXIETY 147 0.0005
370 SKIN WARM 3 0.0005
371 HAEMORRHOIDS 10 0.0005
372 THROAT IRRITATION 23 0.0005
373 EYE SWELLING 19 0.0005
374 PERIPHERAL COLDNESS 7 0.0005
375 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
376 FURUNCLE 4 0.0005
377 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
378 SCIATICA 8 0.0005
379 PROTHROMBIN TIME PROLONGED 3 0.0005
380 APHONIA 7 0.0005
381 BLOOD DISORDER 4 0.0005
382 CANDIDIASIS 2 0.0005
383 BLEPHARITIS 2 0.0005
384 ARTERIOSPASM CORONARY 2 0.0005
385 GASTRITIS 13 0.0005
386 BONE DISORDER 9 0.0005
387 PANIC ATTACK 18 0.0005
388 CHEST PAIN 91 0.0005
389 EMOTIONAL DISORDER 15 0.0005
390 PIGMENTATION DISORDER 3 0.0005
391 CONJUNCTIVITIS 9 0.0005
392 HEPATIC STEATOSIS 9 0.0005
393 DISTURBANCE IN ATTENTION 26 0.0005
394 DISORIENTATION 19 0.0005
395 PHOTOPHOBIA 9 0.0005
396 PRODUCT USE IN UNAPPROVED INDICATION 118 0.0005
397 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
398 BUNDLE BRANCH BLOCK LEFT 2 0.0005
399 SCREAMING 3 0.0005
400 SCAR 8 0.0005
401 ALCOHOLISM 2 0.0005
402 MUSCULOSKELETAL DISCOMFORT 8 0.0005
403 INCOHERENT 3 0.0005
404 HIATUS HERNIA 6 0.0005
405 NIGHTMARE 16 0.0005
406 THERAPEUTIC RESPONSE DECREASED 28 0.0005
407 SWELLING FACE 30 0.0005
408 BIPOLAR DISORDER 5 0.0005
409 BRONCHITIS 34 0.0005
410 POLYP 3 0.0005
411 LOCALISED INFECTION 11 0.0005
412 COLD SWEAT 8 0.0005
413 FIBROMYALGIA 11 0.0005
414 MUSCULOSKELETAL CHEST PAIN 7 0.0005
415 ASTHMA 51 0.0005
416 EAR INFECTION 12 0.0005
417 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
418 OCULAR DISCOMFORT 5 0.0004
419 BLOOD CALCIUM DECREASED 5 0.0004
420 WRONG PRODUCT ADMINISTERED 3 0.0004
421 ANGER 15 0.0004
422 OROPHARYNGEAL DISCOMFORT 4 0.0004
423 EYE INFECTION 5 0.0004
424 LEUKOCYTOSIS 8 0.0004
425 CHOLECYSTECTOMY 5 0.0004
426 RESPIRATION ABNORMAL 3 0.0004
427 MUSCLE TWITCHING 10 0.0004
428 HAIR GROWTH ABNORMAL 3 0.0004
429 HYPERSENSITIVITY 80 0.0004
430 PERSONALITY CHANGE 4 0.0004
431 EXTRASYSTOLES 3 0.0004
432 CHEST DISCOMFORT 44 0.0004
433 ABNORMAL BEHAVIOUR 17 0.0004
434 NEPHROPATHY 4 0.0004
435 TREMOR 71 0.0004
436 SEXUAL DYSFUNCTION 5 0.0004
437 EYE PAIN 24 0.0004
438 BLOOD PROLACTIN INCREASED 2 0.0004
439 BACTERAEMIA 5 0.0004
440 PULMONARY EMBOLISM 40 0.0004
441 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
442 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
443 PARAESTHESIA ORAL 6 0.0004
444 AFFECT LABILITY 4 0.0004
445 VISUAL FIELD DEFECT 3 0.0004
446 TONGUE DISORDER 3 0.0004
447 SINUS BRADYCARDIA 4 0.0004
448 DIZZINESS POSTURAL 4 0.0004
449 NOCTURIA 5 0.0004
450 MAJOR DEPRESSION 3 0.0004
451 OROPHARYNGEAL PAIN 38 0.0004
452 VITAMIN D DEFICIENCY 4 0.0004
453 MOUTH HAEMORRHAGE 3 0.0004
454 COELIAC DISEASE 4 0.0004
455 BLOOD CHOLESTEROL INCREASED 19 0.0004
456 BREATH SOUNDS ABNORMAL 2 0.0004
457 CEREBRAL DISORDER 3 0.0004
458 HYPERCALCAEMIA 5 0.0004
459 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
460 SKIN HAEMORRHAGE 6 0.0004
461 DIABETIC NEUROPATHY 2 0.0004
462 CONVULSION 23 0.0004
463 RASH PAPULAR 9 0.0004
464 LOCAL SWELLING 7 0.0004
465 HYPOAESTHESIA 60 0.0004
466 CHROMATURIA 9 0.0004
467 PRODUCT PHYSICAL ISSUE 8 0.0004
468 TENDON PAIN 3 0.0004
469 AORTIC ANEURYSM 3 0.0004
470 DYSPHONIA 23 0.0004
471 TOOTH ABSCESS 4 0.0004
472 FEELING HOT 24 0.0004
473 VIRAL INFECTION 13 0.0004
474 DYSGEUSIA 29 0.0004
475 PAIN IN JAW 11 0.0004
476 EPISTAXIS 29 0.0004
477 CONGENITAL ANOMALY 3 0.0004
478 CONCUSSION 3 0.0004
479 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
480 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
481 CRYING 14 0.0004
482 HAEMORRHAGIC STROKE 3 0.0004
483 APLASTIC ANAEMIA 2 0.0004
484 ROAD TRAFFIC ACCIDENT 16 0.0004
485 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
486 AFFECTIVE DISORDER 3 0.0004
487 ANKYLOSING SPONDYLITIS 5 0.0004
488 BLOOD ALBUMIN DECREASED 3 0.0004
489 RENAL CYST 3 0.0004
490 RENAL PAIN 4 0.0004
491 ADVERSE REACTION 5 0.0004
492 IMPAIRED WORK ABILITY 8 0.0004
493 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
494 HEREDITARY ANGIOEDEMA 4 0.0004
495 SKIN CANCER 8 0.0004
496 MUSCLE TIGHTNESS 6 0.0004
497 PRURITUS GENERALISED 8 0.0004
498 BLOOD POTASSIUM INCREASED 6 0.0004
499 SKIN LACERATION 4 0.0004
500 BACK INJURY 4 0.0004
501 PULMONARY THROMBOSIS 4 0.0004
502 HEADACHE 230 0.0004
503 CONSTIPATION 80 0.0004
504 CHILLS 43 0.0004
505 MOOD ALTERED 10 0.0004
506 POLYURIA 3 0.0004
507 GINGIVAL BLEEDING 5 0.0004
508 POST PROCEDURAL COMPLICATION 7 0.0004
509 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
510 COUGH 102 0.0004
511 GLAUCOMA 7 0.0004
512 SPINAL COMPRESSION FRACTURE 3 0.0004
513 MENSTRUAL DISORDER 3 0.0004
514 HERNIA 7 0.0004
515 DENTAL CARIES 4 0.0004
516 FOOT DEFORMITY 4 0.0004
517 DIVERTICULITIS 10 0.0004
518 AGEUSIA 9 0.0004
519 EOSINOPHIL COUNT INCREASED 3 0.0004
520 ORAL DISCOMFORT 5 0.0004
521 AGGRESSION 18 0.0004
522 ORAL HERPES 7 0.0004
523 DRUG ADMINISTRATION ERROR 11 0.0004
524 OCULAR HYPERAEMIA 17 0.0004
525 SKIN INFECTION 4 0.0004
526 UNDERDOSE 26 0.0004
527 SINUS TACHYCARDIA 5 0.0004
528 IMPAIRED DRIVING ABILITY 4 0.0004
529 ABDOMINAL DISCOMFORT 59 0.0004
530 ANURIA 3 0.0003
531 DEPRESSION 79 0.0003
532 BLOOD URIC ACID INCREASED 2 0.0003
533 SKIN SWELLING 3 0.0003
534 DYSPEPSIA 34 0.0003
535 HALLUCINATION 26 0.0003
536 POST PROCEDURAL HAEMORRHAGE 4 0.0003
537 VASCULITIS 4 0.0003
538 GASTROENTERITIS 5 0.0003
539 RIB FRACTURE 7 0.0003
540 LUNG INFILTRATION 3 0.0003
541 WRONG DRUG ADMINISTERED 3 0.0003
542 OEDEMA PERIPHERAL 41 0.0003
543 PRODUCTIVE COUGH 16 0.0003
544 FLATULENCE 19 0.0003
545 GASTROINTESTINAL INFECTION 3 0.0003
546 MYOSITIS 3 0.0003
547 DERMATITIS 7 0.0003
548 ADVERSE DRUG REACTION 30 0.0003
549 STAPHYLOCOCCAL INFECTION 11 0.0003
550 DYSPNOEA 188 0.0003
551 PALLOR 9 0.0003
552 VERTIGO 20 0.0003
553 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 66 0.0003
554 NERVE COMPRESSION 3 0.0003
555 MIGRAINE 31 0.0003
556 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
557 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
558 AMNESIA 21 0.0003
559 NECK PAIN 18 0.0003
560 DEPRESSED MOOD 17 0.0003
561 DIARRHOEA HAEMORRHAGIC 3 0.0003
562 VISION BLURRED 44 0.0003
563 SWOLLEN TONGUE 10 0.0003
564 SECRETION DISCHARGE 4 0.0003
565 CATARACT 19 0.0003
566 BLEPHAROSPASM 2 0.0003
567 SUICIDAL IDEATION 29 0.0003
568 ABDOMINAL PAIN UPPER 65 0.0003
569 HALLUCINATION, AUDITORY 5 0.0003
570 INCREASED APPETITE 6 0.0003
571 OBESITY 5 0.0003
572 ABSCESS 5 0.0003
573 HYPOTHYROIDISM 10 0.0003
574 ORAL PAIN 7 0.0003
575 SENSORY DISTURBANCE 5 0.0003
576 NIGHT SWEATS 10 0.0003
577 ERUCTATION 6 0.0003
578 EAR PAIN 6 0.0003
579 HEPATOMEGALY 3 0.0003
580 BODY TEMPERATURE DECREASED 3 0.0003
581 PSYCHOTIC DISORDER 9 0.0003
582 ANHEDONIA 8 0.0003
583 LOSS OF CONSCIOUSNESS 39 0.0003
584 WHEEZING 18 0.0003
585 TOOTH INFECTION 4 0.0003
586 INCORRECT DOSE ADMINISTERED 69 0.0003
587 UPPER LIMB FRACTURE 6 0.0003
588 DRY EYE 15 0.0003
589 EYE HAEMORRHAGE 4 0.0003
590 PARAESTHESIA 47 0.0003
591 EMOTIONAL DISTRESS 36 0.0003
592 TYPE 2 DIABETES MELLITUS 10 0.0003
593 VAGINAL DISCHARGE 3 0.0003
594 HYPOTHERMIA 3 0.0003
595 THROAT TIGHTNESS 8 0.0003
596 ARRHYTHMIA 14 0.0003
597 EYE IRRITATION 17 0.0003
598 OEDEMA 16 0.0003
599 MOTOR DYSFUNCTION 3 0.0003
600 ABNORMAL LOSS OF WEIGHT 2 0.0003
601 NASOPHARYNGITIS 54 0.0003
602 HYPERTENSION 62 0.0003
603 BLOOD TESTOSTERONE DECREASED 2 0.0003
604 DEHYDRATION 39 0.0003
605 GASTRIC DISORDER 10 0.0003
606 FEMUR FRACTURE 9 0.0003
607 PARANOIA 5 0.0003
608 VENTRICULAR EXTRASYSTOLES 3 0.0003
609 PRESYNCOPE 7 0.0003
610 PETECHIAE 3 0.0003
611 ASTHENIA 108 0.0003
612 HUNGER 4 0.0003
613 COORDINATION ABNORMAL 4 0.0003
614 WEIGHT FLUCTUATION 3 0.0003
615 PRODUCT ODOUR ABNORMAL 3 0.0003
616 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
617 DERMATITIS ATOPIC 15 0.0003
618 INCONTINENCE 3 0.0003
619 CONDITION AGGRAVATED 86 0.0003
620 RENAL FAILURE ACUTE 12 0.0003
621 CYSTITIS 9 0.0003
622 TACHYCARDIA 25 0.0003
623 BREAST CANCER METASTATIC 3 0.0003
624 HYPERSOMNIA 8 0.0003
625 DISCOMFORT 17 0.0003
626 OVERDOSE 60 0.0003
627 DECREASED ACTIVITY 3 0.0003
628 ABDOMINAL PAIN LOWER 7 0.0003
629 OESOPHAGITIS 3 0.0003
630 GASTROINTESTINAL PAIN 3 0.0003
631 MUSCLE SPASMS 50 0.0003
632 ACUTE MYOCARDIAL INFARCTION 8 0.0003
633 ADVERSE EVENT 25 0.0003
634 SYNCOPE 27 0.0003
635 DIPLOPIA 7 0.0003
636 DEAFNESS 7 0.0003
637 ECZEMA 14 0.0003
638 SPEECH DISORDER 14 0.0003
639 BACK PAIN 62 0.0003
640 HEART RATE IRREGULAR 6 0.0003
641 HEPATIC FAILURE 8 0.0003
642 APHASIA 8 0.0003
643 FATIGUE 206 0.0003
644 NAUSEA 209 0.0003
645 ECONOMIC PROBLEM 4 0.0003
646 COLITIS 10 0.0003
647 FOOT FRACTURE 5 0.0003
648 BLOOD URINE PRESENT 5 0.0003
649 DERMATITIS CONTACT 3 0.0003
650 DRUG DISPENSING ERROR 4 0.0003
651 DISSOCIATION 2 0.0003
652 LETHARGY 15 0.0003
653 LOWER LIMB FRACTURE 5 0.0003
654 CEREBROVASCULAR ACCIDENT 44 0.0003
655 THYROID DISORDER 4 0.0003
656 EYELID OEDEMA 3 0.0003
657 CELLULITIS 13 0.0003
658 ABDOMINAL PAIN 60 0.0003
659 APHTHOUS ULCER 2 0.0003
660 DELUSION 4 0.0003
661 APNOEA 2 0.0003
662 SKIN FISSURES 5 0.0003
663 FLUSHING 26 0.0003
664 PAIN IN EXTREMITY 75 0.0003
665 BALANCE DISORDER 22 0.0003
666 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
667 BLOOD PRESSURE ABNORMAL 5 0.0003
668 MOOD SWINGS 8 0.0003
669 ATRIAL FLUTTER 2 0.0003
670 PREGNANCY 5 0.0002
671 DIABETES MELLITUS 19 0.0002
672 MENTAL IMPAIRMENT 6 0.0002
673 STOMATITIS 15 0.0002
674 NEURALGIA 6 0.0002
675 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
676 DECUBITUS ULCER 2 0.0002
677 ABNORMAL FAECES 2 0.0002
678 IMPAIRED HEALING 8 0.0002
679 EYE DISORDER 8 0.0002
680 MANIA 4 0.0002
681 OSTEONECROSIS OF JAW 6 0.0002
682 DYSPHAGIA 23 0.0002
683 MALAISE 106 0.0002
684 ACUTE CORONARY SYNDROME 2 0.0002
685 LIVER FUNCTION TEST ABNORMAL 7 0.0002
686 PULMONARY HYPERTENSION 5 0.0002
687 MUSCULOSKELETAL STIFFNESS 21 0.0002
688 BLOOD UREA INCREASED 4 0.0002
689 MOUTH ULCERATION 5 0.0002
690 HALLUCINATION, VISUAL 5 0.0002
691 DECREASED APPETITE 55 0.0002
692 CARDIAC FAILURE CONGESTIVE 19 0.0002
693 URINARY INCONTINENCE 7 0.0002
694 FLUID RETENTION 12 0.0002
695 EATING DISORDER 5 0.0002
696 INTRAOCULAR PRESSURE INCREASED 3 0.0002
697 HEPATIC ENZYME INCREASED 16 0.0002
698 METRORRHAGIA 4 0.0002
699 ERECTILE DYSFUNCTION 6 0.0002
700 DRUG RESISTANCE 6 0.0002
701 BLOOD POTASSIUM DECREASED 7 0.0002
702 BLOOD MAGNESIUM DECREASED 2 0.0002
703 HAEMATOMA 6 0.0002
704 INJECTION SITE INDURATION 3 0.0002
705 DISEASE RECURRENCE 11 0.0002
706 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
707 FAECES DISCOLOURED 5 0.0002
708 PLATELET COUNT INCREASED 3 0.0002
709 VOMITING 108 0.0002
710 RASH 100 0.0002
711 JOINT STIFFNESS 6 0.0002
712 DRUG WITHDRAWAL SYNDROME 20 0.0002
713 IMMUNE SYSTEM DISORDER 3 0.0002
714 INJECTION SITE BRUISING 18 0.0002
715 CARDIAC DISORDER 21 0.0002
716 SWELLING 21 0.0002
717 GOUT 4 0.0002
718 ANAL INCONTINENCE 2 0.0002
719 DEVELOPMENTAL DELAY 2 0.0002
720 GASTROENTERITIS VIRAL 4 0.0002
721 OSTEOMYELITIS 4 0.0002
722 NEUROPATHY PERIPHERAL 21 0.0002
723 DRUG TOXICITY 3 0.0002
724 MUSCULAR WEAKNESS 25 0.0002
725 OSTEOPOROSIS 9 0.0002
726 SKIN LESION 6 0.0002
727 INJECTION SITE ERYTHEMA 27 0.0002
728 MYALGIA 37 0.0002
729 HAEMATOCHEZIA 12 0.0002
730 ANAPHYLACTIC REACTION 12 0.0002
731 CONFUSIONAL STATE 35 0.0002
732 FEELING COLD 6 0.0002
733 PLEURAL EFFUSION 13 0.0002
734 HEPATIC CIRRHOSIS 4 0.0002
735 ARTERIOSCLEROSIS 2 0.0002
736 ABORTION INDUCED 2 0.0002
737 HOT FLUSH 16 0.0002
738 ARTHRALGIA 88 0.0002
739 ABDOMINAL DISTENSION 22 0.0002
740 BRONCHOSPASM 3 0.0002
741 PAIN 129 0.0002
742 DRY SKIN 28 0.0002
743 RECTAL HAEMORRHAGE 9 0.0002
744 RASH ERYTHEMATOUS 10 0.0002
745 PULMONARY FIBROSIS 4 0.0002
746 PANCREATITIS 11 0.0002
747 CONTUSION 20 0.0002
748 INJECTION SITE HAEMATOMA 3 0.0002
749 HYPOKINESIA 3 0.0002
750 WEIGHT INCREASED 46 0.0002
751 BONE PAIN 12 0.0002
752 ARTHRITIS 16 0.0002
753 DISABILITY 4 0.0002
754 COLITIS ULCERATIVE 9 0.0002
755 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
756 PULMONARY OEDEMA 9 0.0002
757 GASTROINTESTINAL DISORDER 18 0.0002
758 MYOCARDIAL INFARCTION 35 0.0002
759 RASH MACULAR 7 0.0002
760 URINARY TRACT INFECTION 34 0.0002
761 HYPOXIA 7 0.0002
762 ARTHROPATHY 11 0.0002
763 MEDICATION ERROR 11 0.0002
764 FEEDING DISORDER 4 0.0002
765 DYSKINESIA 8 0.0002
766 NEPHROLITHIASIS 9 0.0002
767 INSURANCE ISSUE 3 0.0002
768 BODY TEMPERATURE INCREASED 4 0.0002
769 HIP ARTHROPLASTY 3 0.0002
770 PRURITUS 75 0.0002
771 LIMB DISCOMFORT 6 0.0002
772 DIARRHOEA 125 0.0002
773 RASH GENERALISED 5 0.0002
774 COGNITIVE DISORDER 9 0.0002
775 INTENTIONAL DRUG MISUSE 4 0.0002
776 CYANOSIS 3 0.0002
777 JOINT SWELLING 23 0.0002
778 WEIGHT DECREASED 53 0.0002
779 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
780 BODY HEIGHT DECREASED 2 0.0002
781 DYSPNOEA EXERTIONAL 7 0.0002
782 JAUNDICE 5 0.0002
783 BURNING SENSATION 13 0.0002
784 ERYTHEMA 38 0.0002
785 LIMB INJURY 5 0.0002
786 PRODUCT DISPENSING ERROR 4 0.0002
787 METASTASES TO BONE 3 0.0002
788 PHOTOSENSITIVITY REACTION 3 0.0002
789 RESPIRATORY DISTRESS 5 0.0002
790 COAGULOPATHY 3 0.0002
791 MENTAL STATUS CHANGES 5 0.0002
792 HAEMOPTYSIS 5 0.0002
793 URTICARIA 30 0.0002
794 GLOSSODYNIA 4 0.0002
795 HEMIPARESIS 3 0.0002
796 EXPOSURE DURING PREGNANCY 11 0.0002
797 PRODUCT QUALITY ISSUE 24 0.0002
798 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
799 DRUG INTOLERANCE 17 0.0002
800 OFF LABEL USE 153 0.0002
801 SKIN DISCOLOURATION 8 0.0002
802 CAESAREAN SECTION 2 0.0002
803 RENAL DISORDER 8 0.0002
804 EOSINOPHILIA 3 0.0002
805 AMENORRHOEA 3 0.0002
806 PYREXIA 59 0.0002
807 INFLUENZA LIKE ILLNESS 14 0.0002
808 LYMPHOCYTE COUNT DECREASED 3 0.0002
809 INJECTION SITE SWELLING 13 0.0002
810 ATAXIA 2 0.0002
811 DRUG DEPENDENCE 27 0.0002
812 GAIT DISTURBANCE 32 0.0002
813 RESPIRATORY DISORDER 5 0.0002
814 FALL 55 0.0002
815 ILLNESS 17 0.0002
816 ABNORMAL WEIGHT GAIN 2 0.0002
817 ABASIA 4 0.0002
818 APPLICATION SITE IRRITATION 2 0.0002
819 NERVOUS SYSTEM DISORDER 5 0.0002
820 BLOOD SODIUM DECREASED 3 0.0002
821 HYPOCALCAEMIA 3 0.0002
822 GASTRIC ULCER 3 0.0002
823 HEPATITIS 4 0.0002
824 THERAPY CESSATION 8 0.0002
825 HIP FRACTURE 5 0.0002
826 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
827 SKIN EXFOLIATION 13 0.0002
828 ATRIAL FIBRILLATION 15 0.0002
829 HAEMORRHAGE 16 0.0002
830 MEMORY IMPAIRMENT 21 0.0002
831 SKIN IRRITATION 7 0.0002
832 OSTEONECROSIS 5 0.0002
833 BEDRIDDEN 2 0.0002
834 ANAEMIA 29 0.0002
835 RESPIRATORY FAILURE 11 0.0002
836 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
837 BLOOD PRESSURE DECREASED 10 0.0002
838 INJECTION SITE HAEMORRHAGE 12 0.0002
839 FUNGAL INFECTION 5 0.0001
840 SKIN DISORDER 5 0.0001
841 MENSTRUATION IRREGULAR 4 0.0001
842 INJECTION SITE PRURITUS 10 0.0001
843 PNEUMONIA 48 0.0001
844 FREQUENT BOWEL MOVEMENTS 4 0.0001
845 TASTE DISORDER 3 0.0001
846 RASH PRURITIC 8 0.0001
847 AKATHISIA 2 0.0001
848 CORONARY ARTERY OCCLUSION 2 0.0001
849 TOOTH LOSS 3 0.0001
850 PROCEDURAL PAIN 4 0.0001
851 INFLUENZA 16 0.0001
852 OXYGEN SATURATION DECREASED 8 0.0001
853 BLOOD TEST ABNORMAL 2 0.0001
854 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
855 JOINT INJURY 3 0.0001
856 INJECTION SITE PAIN 43 0.0001
857 RED BLOOD CELL COUNT DECREASED 4 0.0001
858 PRODUCT SUBSTITUTION ISSUE 8 0.0001
859 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
860 MENTAL DISORDER 6 0.0001
861 HYPERGLYCAEMIA 5 0.0001
862 VISUAL IMPAIRMENT 17 0.0001
863 APATHY 2 0.0001
864 INFLAMMATION 7 0.0001
865 STEVENS-JOHNSON SYNDROME 3 0.0001
866 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
867 CARDIAC ARREST 11 0.0001
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
869 DYSARTHRIA 5 0.0001
870 BLOOD GLUCOSE INCREASED 25 0.0001
871 APPLICATION SITE PRURITUS 3 0.0001
872 BLOOD COUNT ABNORMAL 2 0.0001
873 DEVICE FAILURE 2 0.0001
874 HYPOKALAEMIA 6 0.0001
875 PERICARDIAL EFFUSION 3 0.0001
876 ANKLE FRACTURE 2 0.0001
877 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
878 BASAL CELL CARCINOMA 2 0.0001
879 TREATMENT NONCOMPLIANCE 7 0.0001
880 DRUG DOSE OMISSION 21 0.0001
881 HEAD INJURY 4 0.0001
882 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
883 INTENTIONAL PRODUCT MISUSE 11 0.0001
884 PANCYTOPENIA 7 0.0001
885 BLOOD PRESSURE FLUCTUATION 3 0.0001
886 HYPOGLYCAEMIA 6 0.0001
887 RHEUMATOID ARTHRITIS 14 0.0001
888 DEVICE BREAKAGE 5 0.0001
889 BACK DISORDER 2 0.0001
890 BLINDNESS 5 0.0001
891 LUNG DISORDER 6 0.0001
892 FEBRILE NEUTROPENIA 8 0.0001
893 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
894 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
895 CANDIDA INFECTION 2 0.0001
896 CARDIOVASCULAR DISORDER 3 0.0001
897 INFECTION 17 0.0001
898 HAEMOGLOBIN DECREASED 12 0.0001
899 HYPOACUSIS 5 0.0001
900 DELIRIUM 4 0.0001
901 SEDATION 3 0.0001
902 MUSCULOSKELETAL PAIN 6 0.0001
903 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
904 DRUG INTERACTION 18 0.0001
905 LYMPHADENOPATHY 4 0.0001
906 RENAL FAILURE 15 0.0001
907 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
908 BREAST CANCER FEMALE 3 0.0001
909 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
910 THROMBOSIS 9 0.0001
911 PAIN OF SKIN 3 0.0001
912 BLOOD BILIRUBIN INCREASED 3 0.0001
913 PNEUMONITIS 3 0.0001
914 RENAL IMPAIRMENT 9 0.0001
915 HYPONATRAEMIA 6 0.0001
916 TARDIVE DYSKINESIA 3 0.0001
917 MULTIPLE SCLEROSIS 5 0.0001
918 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
919 CHOLESTASIS 2 0.0001
920 BLOOD GLUCOSE DECREASED 5 0.0001
921 ACUTE RESPIRATORY FAILURE 2 0.0001
922 DYSSTASIA 3 0.0001
923 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
924 PLASMA CELL MYELOMA 4 0.0001
925 SURGERY 6 0.0001
926 INJECTION SITE REACTION 7 0.0001
927 LABORATORY TEST ABNORMAL 3 0.0001
928 SUICIDE ATTEMPT 6 0.0001
929 INJECTION SITE RASH 3 0.0001
930 COVID-19 17 0.0001
931 ALOPECIA 19 0.0001
932 INTENTIONAL OVERDOSE 6 0.0001
933 MOVEMENT DISORDER 3 0.0001
934 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
935 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
936 INFUSION RELATED REACTION 6 0.0001
937 ANGIOEDEMA 4 0.0001
938 VISUAL ACUITY REDUCED 3 0.0001
939 HYPERKALAEMIA 3 0.0001
940 DEVICE MALFUNCTION 6 0.0001
941 PLATELET COUNT DECREASED 9 0.0001
942 COMA 4 0.0001
943 MOBILITY DECREASED 6 0.0001
944 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
945 INTERSTITIAL LUNG DISEASE 4 0.0001
946 ILL-DEFINED DISORDER 5 0.0001
947 CEREBRAL INFARCTION 2 0.0001
948 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
949 SEPSIS 9 0.0001
950 INTESTINAL OBSTRUCTION 3 0.0001
951 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
952 NEOPLASM MALIGNANT 5 0.0001
953 ABORTION SPONTANEOUS 3 0.0001
954 PRODUCT DOSE OMISSION ISSUE 22 0.0001
955 HYPOTENSION 15 0.0001
956 PSORIATIC ARTHROPATHY 3 0.0001
957 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
958 DEMENTIA 2 0.0001
959 WITHDRAWAL SYNDROME 3 0.0001
960 HERPES ZOSTER 4 0.0001
961 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
962 SEIZURE 8 0.0001
963 VAGINAL HAEMORRHAGE 3 0.0001
964 PSORIASIS 9 0.0001
965 LIVER DISORDER 3 0.0001
966 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
967 ACNE 5 0.0001
968 CHRONIC KIDNEY DISEASE 5 0.0001
969 PERIPHERAL SWELLING 10 0.0001
970 BREAST CANCER 6 0.0001
971 THROMBOCYTOPENIA 7 0.0001
972 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
973 BLOOD CREATININE INCREASED 4 0.0001
974 NEUTROPENIA 8 0.0001
975 PRODUCT STORAGE ERROR 5 0.0001
976 SKIN BURNING SENSATION 4 0.0001
977 NO ADVERSE EVENT 10 0.0001
978 BLISTER 3 0.0001
979 CARDIO-RESPIRATORY ARREST 2 0.0000
980 DEVICE EXPULSION 3 0.0000
981 DEVICE ISSUE 4 0.0000
982 DISEASE PROGRESSION 5 0.0000
983 THERAPY INTERRUPTED 3 0.0000
984 BRADYCARDIA 2 0.0000
985 CARDIAC FAILURE 3 0.0000
986 DEPENDENCE 2 0.0000
987 ACUTE KIDNEY INJURY 5 0.0000
988 HOSPITALISATION 5 0.0000
989 DEVICE DIFFICULT TO USE 2 0.0000
990 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
991 DEATH 22 0.0000
992 COMPLETED SUICIDE 2 0.0000
993 TOXICITY TO VARIOUS AGENTS 4 0.0000